4g5z

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:4g5z.jpg|left|200px]]
 
- 
{{STRUCTURE_4g5z| PDB=4g5z | SCENE= }}
{{STRUCTURE_4g5z| PDB=4g5z | SCENE= }}
- 
===Crystal structure of the therapeutical antibody fragment of canakinumab in its unbound state===
===Crystal structure of the therapeutical antibody fragment of canakinumab in its unbound state===
- 
{{ABSTRACT_PUBMED_23041424}}
{{ABSTRACT_PUBMED_23041424}}
==About this Structure==
==About this Structure==
[[4g5z]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4G5Z OCA].
[[4g5z]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4G5Z OCA].
 +
 +
==See Also==
 +
*[[Monoclonal Antibody|Monoclonal Antibody]]
 +
 +
==Reference==
 +
<ref group="xtra">PMID:023041424</ref><references group="xtra"/><references/>
[[Category: Blech, M.]]
[[Category: Blech, M.]]
[[Category: Hoerer, S.]]
[[Category: Hoerer, S.]]

Revision as of 04:35, 18 July 2013

Template:STRUCTURE 4g5z

Contents

Crystal structure of the therapeutical antibody fragment of canakinumab in its unbound state

Template:ABSTRACT PUBMED 23041424

About this Structure

4g5z is a 2 chain structure. Full crystallographic information is available from OCA.

See Also

Reference

  • Blech M, Peter D, Fischer P, Bauer MM, Hafner M, Zeeb M, Nar H. One Target-Two Different Binding Modes: Structural Insights into Gevokizumab and Canakinumab Interactions to Interleukin-1beta J Mol Biol. 2012 Oct 3. pii: S0022-2836(12)00786-3. doi:, 10.1016/j.jmb.2012.09.021. PMID:23041424 doi:10.1016/j.jmb.2012.09.021

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools